AKT1 and Alzheimer disease: Specifically, we demonstrated that hDPSCs significantly improved cognitive decline and intracranial microenvironment in AD mice and that the beneficial effects were largely dependent on AKT/GSK3β-mediated Nrf2 activation and nuclear accumulation.